Panacea Biotec Ltd (PNCA.NS) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Panacea Biotec Ltd approves to raise funds


Friday, 1 Aug 2014 10:37am EDT 

Panacea Biotec Ltd:Approved to raise funds by way of issue of equity shares and/or other securities, etc aggregating upto 2.50 bln Indian Rupees or equivalent thereof in any currency. 

Latest Developments forPanacea Biotec Ltd

Company Quote

114.8
-3.95 -3.33%
24 Jun 2016